Association of polymorphisms in the collagen region of human SP-A1 and SP-A2 genes with pulmonary tuberculosis in Indian population

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 10, 2002, Pages 1002-1008

  Madan, Taruna ^a   Saxena, Shweta ^a   Murthy, Kolluri J R ^a   Muralidhar, Kambadur ^a   Usha Sarma, Puranam ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Collagen; Human ling surfactant protein A: SP A; Single nucleotide polymorphism; Tuberculosis

Indexed keywords

COLLAGEN; SURFACTANT PROTEIN A; DRUG DERIVATIVE; SFTPA1 PROTEIN, HUMAN; SFTPA2 PROTEIN, HUMAN;

ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EXON; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; INDIA; INTRON; LUNG TUBERCULOSIS; POPULATION RESEARCH; PRIORITY JOURNAL; REDUNDANCY ANALYSIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; AMINO ACID SEQUENCE; GENE FREQUENCY; GENETICS; MOLECULAR GENETICS; PROMOTER REGION;

MOLVA MOLVA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

AMINO ACID SEQUENCE; COLLAGEN; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDIA; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; TUBERCULOSIS, PULMONARY;

EID: 0036430733     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.174     Document Type: Article

References (38)

1. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. J Am Med Assoc 1995; 273:220-6.
2. Balasubramanian V, Weigeshaus EH, Taylor BT, Smith DW. Pathogenesis of tuberculosis: pathway to apical localization. Tuber Lung Dis 1994; 75:168-78.
3. Schluger NW, Rom WN. The host immune response to tuberculosis. Am J Respir Crit Care Med 1998; 157:679-91.
4. Mason RJ, Greene K, Voelker DR. Surfactant protein A and surfactant protein D in health and disease. Am J Physiol 1998; 275:L1-13.
5. Madan T, Kishore U, Singh M, Strong P, Clark H, Hussain EM, et al. Surfactant protein A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus. J Clin Invest 2001; 107:467-75.
6. Madan T, Kishore U, Singh M, Strong P, Hussain EM, Reid KBM, et al. Protective role of lung surfactant protein D in a murine model of invasive pulmonary Aspergillosis. Infect Immun 2001; 69:2728-31.
7. Madan T, Eggleton P, Kishore U, Aggarwal SS, Sarma PU, Reid KBM. Binding of pulmonary surfactant protein A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and macrophage. Infect Immun 1997; 65:3171-9.
8. Madan T, Kishore U, Eggleton P, Aggarwal SS, Sarma PU, Reid KBM. Lung surfactant protein A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils. Clin Exp Immunol 1997; 110:241-9.
9. Gaynor CD, McCormack FX, Voelker DR, Mc Gowan SE, Schlesinger LS. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunol 1995; 155:5343-51.
10. Pasula R, Downing JF, Wright JR, Kachel DL, Davis TE Jr, Martin WJ 2nd. Surfactant protein A (SP-A) mediates attachment of Mycobacterium tuberculosis to murine alveolar macrophages. Am J Respir Cell Mol Biol 1997; 17:209-17.
11. Weikert LF, Edwards K, Chroneos ZC, Hager C, Hoffman L, Shepherd VL. SP-A enhances uptake of bacillus Calmette-Guerin by macrophages through a specific SP-A receptor. Am J Physiol 1997; 272:L989-95.
12. Crouch EC. Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 1998; 19:177-201.
13. Hoover RR, Floros J. Organization of the human SP-A and SP-D loci at 10q22-q23. Physical and radiation hybrid mapping reveal gene order and orientation. Am J Respir Cell Mol Biol 1998; 18:353-62.
14. McCormick SM, Boggaram V, Mendelson CR. Characterization of mRNA transcripts and organization of human SP-A1 and SP-A2 genes. Am J Physiol 1994; 266:354-66.
15. Kumar AR, Snyder JM. Differential regulation of SP-A1 and SP-A2 genes by cAMP, glucocorticoids, and insulin. Am J Physiol 1998; 274:177-85.
16. DiAngelo S, Lin Z, Wang G, Phillips S, Ramet M, Luo J, et al. Novel, non-radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers 1999; 15:269-81.
17. Wang G, Umstead TM, Phelps DS, Al-Mondhiry H, Floros J. The effect of ozone exposure on the ability of human surfactant protein a variants to stimulate cytokine production. Environ Health Perspect 2002; 110:79-84.
18. Karinch AM, deMello DE, Floros J. Effect of genotype on the levels of surfactant protein A mRNA and on the SP-A2 splice variants in adult humans. Biochem J 1997; 321:39-47.
19. Kala P, Ten Have T, Nielsen H, Dunn M, Floros J. Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome: interaction with SP-B. Pediatr Res 1998; 43:169-77.
20. Ramet M, Haataja R, Marttila R, Hamalainen AM, Knip M, Hallman M. Human surfactant protein-A gene locus for genetic studies in the Finnish population. Dis Markers 2000; 16:119-24.
21. Guo X, Lin HM, Lin Z, Montano M, Sansores R, Wang G, et al. Polymorphisms of surfactant protein gene A, B, D, and of SP-B-linked microsatellite markers in COPD of a Mexican population. Chest 2000; 117:249S-50S.
22. Floros J, Lin HM, Garcia A, Salazar MA, Guo X, DiAngelo S, et al. Surfactant protein genetic marker alleles identify a subgroup of tuberculosis in a Mexican population. J Infect Dis 2000; 182:1473-8.
23. McCormack FX, Damodarasamy M, Elhalwagi BM. Deletion mapping of N-terminal domains of surfactant protein A. The N-terminal segment is required for phospholipid aggregation and specific inhibition of surfactant secretion. J Biol Chem 1999; 274:3173-81.
24. Dobbeling U, Boni R, Haffner A, Dummer R, Burg G. Method for simultaneous RNA and DNA isolation from biopsy material, culture cells, plants and bacteria. Biotechniques 1997; 22:88-90.
25. Lin Z, Pearson C, Chinchilli V, Pietschmann SM, Luo J, Pison U, et al. Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131lle with ARDS. Clin Genet 2000; 58:181-91.
26. Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 1990; 322:422-7.
27. Stead WW. Genetics and resistance to tuberculosis. Could resistance be enhanced by genetic engineering? Ann Intern Med 1992; 116:937-41.
28. Kallmann FJ, Reisner D. Twin studies on the significance of genetic factors on tuberculosis. Am Rev Tuberc 1942; 47:549-74.
29. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit study. Am Rev Respir Dis 1978; 117:621-4.
30. Takiff H. The role of human genetic factors in susceptibility to tuberculosis. Acta Cient Venez 2001; 52 Suppl 1:16-8.
31. Bellamy R. Identifying genetic susceptibility factors for tuberculosis in Africans: a combined approach using a candidate gene study and a genome-wide screen. Clin Sci 2000; 98:245-50.
32. Selvaraj P, Narayanan PR, Reetha AM. Association of vitamin D receptor genotypes with the susceptibility to pulmonary tuberculosis in female patients and resistance in female contacts. Indian J Med Res 2000; 111:172-9.
33. Korfhagen TR, Bruno MD, Ross GF, Huelsman KM, Ikegami M, Jobe AH, et al. Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 1996; 93:9594-9.
34. LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, Korfhagen TR. Surfactant protein-A deficient mice are susceptible to group B streptococcal infection. J Immunol 1997; 158:4336-40.
35. LeVine AM, Gwozdz J, Stark J, Bruno MD, Whitsett JA, Korfhagen TR. Surfactant protein-A enhances respiraory syncytial virus clearance in vivo. J Clin Invest 1999; 103:1015-21.
36. Floros J, Hoover RR. Genetics of the hydrophilic surfactant proteins A and D. Biochim Biophys Acta 1998; 1408: 312-22.
37. Improta R, Benzi C, Barone V. Understanding the role of stereoelectronic effects in determining collagen stability. A quantum mechanical study of proline, hydroxyproline, and fluoroproline dipeptide analogues in aqueous solution. J Am Chem Soc 2001; 123:12568-77.
38. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349:1436-42.